Journal of Life Science and Biomedicine
ISSN: 2251-9939; http://jlsb.science-line.com
How to Cite this Article
APA:
Ibadov, R. A., ARIFJANOV, A. S., IBRAGIMOV, rdor K., & KHAKIMOV, B. B. (2021). Dexmedetomidine for sedation and correction of psychoemotional disorders in critically ill patients with COVID-19. Journal of Life Science and Biomedicine, 11(4), 80–87. doi:10.51145/jlsb.2021.10
Harvard:
Ibadov, R.A. et al., 2021. Dexmedetomidine for sedation and correction of psychoemotional disorders in critically ill patients with COVID-19. Journal of Life Science and Biomedicine, 11(4), pp.80–87. Available at: http://dx.doi.org/10.51145/jlsb.2021.10.
IEEE:
[1]R. A. Ibadov, A. S. ARIFJANOV, rdor K. IBRAGIMOV, and B. B. KHAKIMOV, “Dexmedetomidine for sedation and correction of psychoemotional disorders in critically ill patients with COVID-19,” Journal of Life Science and Biomedicine, vol. 11, no. 4, pp. 80–87, Jul. 2021.
MLA:
Ibadov, Ravshan Aliyevich et al. “Dexmedetomidine for Sedation and Correction of Psychoemotional Disorders in Critically Ill Patients with COVID-19.” Journal of Life Science and Biomedicine 11.4 (2021): 80–87. Crossref. Web.
Vancouver:
1. Ibadov RA, ARIFJANOV AS, IBRAGIMOV rdor K, KHAKIMOV BB. Dexmedetomidine for sedation and correction of psychoemotional disorders in critically ill patients with COVID-19. Journal of Life Science and Biomedicine [Internet]. Journal of Life Science and Biomedicine; 2021 Jul 25;11(4):80–7. Available from: http://dx.doi.org/10.51145/jlsb.2021.10
Chicago:
Ibadov, Ravshan Aliyevich, Anvar Shamkhatovich ARIFJANOV, rdor Khamdamovich IBRAGIMOV, and Begali Bobokulovich KHAKIMOV. “Dexmedetomidine for Sedation and Correction of Psychoemotional Disorders in Critically Ill Patients with COVID-19.” Journal of Life Science and Biomedicine 11, no. 4 (July 25, 2021): 80–87. doi:10.51145/jlsb.2021.10.